Implementation of activities and research focused on the antidepressant potential of the psychedelics psilocybin and ketamine, and on the neurobiology of the antidepressant effect
Basic information
Investigator: MUDr. Tomáš Páleníček, Ph.D.
Main recipient: NIMH (National Institute of Mental Health)
Co-recipient: n/a
Research period: 1/01/2026 – 31/12/2026
Total budget: 1,300,000.00 CZK
NIMH budget: 1,300,000.00 CZK
Supported by: OTHERS
Annotation
The foundation's contribution will cover personnel costs for research focused on the therapeutic potential of psychedelics, particularly psilocybin, ketamine, 5-MeO-DMT, and the neurobiology of their effects.